4-83284533-T-C
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBS1_Supporting
The NM_001358921.2(COQ2):āc.232A>Gā(p.Met78Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000165 in 1,576,378 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001358921.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COQ2 | ENST00000647002.2 | c.232A>G | p.Met78Val | missense_variant | Exon 1 of 7 | NM_001358921.2 | ENSP00000495761.2 | |||
COQ2 | ENST00000311469.9 | c.382A>G | p.Met128Val | missense_variant | Exon 1 of 7 | 1 | ENSP00000310873.4 | |||
COQ2 | ENST00000311461.7 | c.232A>G | p.Met78Val | missense_variant | Exon 1 of 7 | 5 | ENSP00000311835.7 | |||
COQ2 | ENST00000503391.5 | n.232A>G | non_coding_transcript_exon_variant | Exon 1 of 7 | 2 | ENSP00000426242.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151932Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000495 AC: 9AN: 181648Hom.: 0 AF XY: 0.0000199 AC XY: 2AN XY: 100282
GnomAD4 exome AF: 0.0000154 AC: 22AN: 1424446Hom.: 0 Cov.: 84 AF XY: 0.0000113 AC XY: 8AN XY: 705924
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151932Hom.: 0 Cov.: 34 AF XY: 0.0000539 AC XY: 4AN XY: 74212
ClinVar
Submissions by phenotype
not provided Uncertain:2
- -
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change affects COQ2 function (PMID: 23758206). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt COQ2 protein function. ClinVar contains an entry for this variant (Variation ID: 60536). This missense change has been observed in individual(s) with multiple system atrophy (PMID: 23758206). This variant is present in population databases (rs778094136, gnomAD 0.07%). This sequence change replaces methionine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 128 of the COQ2 protein (p.Met128Val). -
Coenzyme Q10 deficiency, primary, 1 Pathogenic:1
Variant summary: COQ2 c.382A>G (p.Met128Val) results in a conservative amino acid change in the encoded protein sequence. Three of four in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 5.2e-05 in 212966 control chromosomes (gnomAD). c.382A>G has been reported in the literature in at least two homozygous siblings affected with Multiple System Atrophy (Multiple-System Atrophy Research Collaboration_2013). These individuals were also homozygous for p.Val343Ala, which is considered a benign polymorphism (ClinVar:214217). These data indicate that the variant is likely to be associated with disease. Several publications have examined the functional impact of the variant: the variant could not rescue growth in a COQ2-null yeast strain (Multiple-System Atrophy Research Collaboration_2013); COQ2-null yeast expressing the the variant had decreased expression of other Coenzyme Q genes (COQ6, Desbats_2016); COQ2-null yeast had reduced oxygen consumption rate compared to wild-type (Yasuda_2019). Two ClinVar submitters have assessed the variant since 2014: one classified the variant as VUS, and one as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Inborn genetic diseases Uncertain:1
The c.382A>G (p.M128V) alteration is located in exon 1 (coding exon 1) of the COQ2 gene. This alteration results from a A to G substitution at nucleotide position 382, causing the methionine (M) at amino acid position 128 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Coenzyme Q10 deficiency, primary, 1;C3714927:Multiple system atrophy 1, susceptibility to Uncertain:1
- -
Multiple system atrophy Other:1
- -
Coenzyme Q10 deficiency Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at